| HOME >> MEDICINE >> TECHNOLOGY |
C&O Pharmaceutical to Distribute Meiact in China 44
Bioton Signs Deal to Market Antibiotics in Russia 44
Toyama Gains Marketing Approval for Geninax® in Japan 44
Forest Laboratories Acquires Cerexa 44
Oscient Modifies Licensing Agreement With LG Life Sciences 44
Orchid Sign Licensing & Distribution Pact With Actavis 45
Forest Laboratories Revokes Partnership With Replidyne 45
SRI and Blanca Collaborate To Develop & Test Carbacephem 45
AstraZeneca To Expand Research Center For Antibiotics 45
Jade Pharmaceutical Begins Levofloxacin's Production in China 45
Reyoung To Start Antibiotic Production At New Facility 46
Toyama Begins T-705 Clinical Trials 46
SmPC For Sanofi-Aventis' Ketek® Updated 46
Lupin Receives Approval for Cefpodoxime Proxetil Antiobiotic
Tablets in France 46
Antibiotice Plans To Infuse Funds For Antibiotics Production 46
UAE Approves Pfizer's Zithromax SD 46
10. PRODUCT INNOVATIONS/INTRODUCTIONS 47
Janssen-Cilag Launches Doribax™ - New Carbapenem Antibiotic 47
MIT Scientists Develop a New Antibiotic, Rhodostreptomycin 47
Watson Pharma Introduces Biaxin XL's Generic Version 47
11. PRODUCT INNOVATIONS IN THE RECENT PAST - A PERSPECTIVE BUILDER 48
Toyama Launches New Garenoxacin Quinolone Antibiotic 48
Wockhardt to Introduce Cefprozil in the US 48
MSD India Launches Invanza in India 48
Orchid Chemicals to Introduce Three New Drugs in the US 48
DUSA Pharmaceuticals Releases ClindaReach™ 49
Mylan Releases Cipro's Generic Version 49
Macrolide Antibiotic Developed In the US 49
University of Michigan Devises NMR Spectroscopy For Antibiotics 49
Glycopeptide-Cephalosporin Antibiotics Developed In The US 49
Neosil Tests NEO 101 Antibiotic 49
New Antibiotic Developed By Canadian Inve
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |